Back to Markets
NBNovaBridge Biosciences

NovaBridge Biosciences

NBP
Health CareBiotechnology: Pharmaceutical Preparations

$1.84

-0.030000 (-1.60%)

As of 05/29/26 EDT · USD

Compare
Low: $1.20Current: $1.84High: $6.79

Key Statistics

Open

$1.89

Day High

$1.91

Day Low

$1.81

Prev. Close

$1.87

VolumeShares traded today.

355.69K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$212.79M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-6.04

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$6.79

52W LowLowest price over the past 52 weeks.

$1.20

50D MAAverage closing price over the last 50 trading days.

$2.30

200D MAAverage closing price over the last 200 trading days.

$3.62

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+3.4%

1M

-21.7%

6M

-52.8%

YTD

-56.9%

1Y

+43.8%

About

Massively parallel sequencing (MPS) is any of several high-throughput approaches to DNA sequencing using the concept of massively parallel processing; it is also called next-generation sequencing (NGS) or second-generation sequencing. Some of these technologies emerged between 1993 and 1998 and have been commercially available since 2005. These technologies use miniaturized and parallelized platforms for sequencing of 1 million to 43 billion short reads per instrument run.

Company Facts

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade NBP

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.